The interview made by Aktiespararna (in English) with Follicum’s CEO Jan Alenfall is now published on our webpage: http://follicum.com/investors/presentations/
Our new webpage, www.follicum.com, will make it much easier to access information about our two, main therapy areas, hair growth and diabetes. The starting page will be the English version, as we need to reach an international audience. – The website makes it smoother and easier to navigate for all stakeholders, says Jan Alenfall, CEO […]
Follicum has recruited Susanne Scheele to the position of Project Manager for the company’s diabetes project. Susanne will commence her new role in January 2018. Susanne Scheele has extensive experience from both the pharmaceutical industry and academic research institutions including Lund and Uppsala Universities. Her previous positions include that of Senior Scientist at Novo Nordisk […]
Follicum AB (“Follicum” or “the company”) announced today that the company will attend a conference in Basel (www.basle-manchester-forum.science) and will also sponsor the conference with a small amount of money. Since the German research group who generated important parts of Follicum’s research data on human skin and human hair follicles will attend the conference, this […]
We like as many of our shareholders and other stakeholders to receive our newsletters. Please find an application on our homepage to register your email for regular updates.
Read the latest newsletter from Follicum here.
An analysis of Follicum AB, conducted by the Swedish Shareholders’ Association, has been published today. The document is only available in Swedish. >Anaysis of Follicum (in Swedish) For more information, please contact: Jan Alenfall, CEO Tel: +46 (0)46 19 21 97 Email: email@example.com
On 16 March, CEO Jan Alenfall will present Follicum at Sedermeradagen in Lund at 16.20-16.50. Sedermeradagen offers an opportunity for investors to meet with companies in the micro- and smallcap segment in Sweden. More information in Swedish
Follicum appoints Maria Ekblad Director R&D as of January 2016. Maria Ekblad has more than twenty years of experience from the pharmaceutical industry where she has held various management positions; the latest as Director Preclinical Development at Active Biotech AB in Lund. At Follicum Ekblad will be responsible for the preclinical development as well as […]